Hematopoietic tumors and metastases involving bone.
This review explores in depth the most common malignant process involving the bone, namely metastatic disease, as well as some of the more common proliferative forms of hematopoietic disease of bone marrow. These are commonly encountered pathologic processes that often have vague nonspecific symptoms. Imaging findings are frequently subtle on initial radiographs; however, advanced imaging techniques, including CT, MR, and positron emission tomography, allow for accurate diagnosis, staging, and follow-up in most cases.
Department of Radiology, University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD 21201, USA.
Sung H
SH
Kim
Stacy E
SE
Smith
Michael E
ME
Mulligan
D001859:Bone Neoplasms / Q000175:diagnosis* / Q000556:secondary*; D019788:Fluorodeoxyglucose F18; D019337:Hematologic Neoplasms / Q000175:diagnosis*; D006646:Histiocytosis, Langerhans-Cell / Q000175:diagnosis; D006801:Humans; D007938:Leukemia / Q000175:diagnosis*; D008223:Lymphoma / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging / Q000379:methods; D009101:Multiple Myeloma / Q000175:diagnosis; D016609:Neoplasms, Second Primary / Q000175:diagnosis*; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals; D013669:Technetium Tc 99m Medronate; D014055:Tomography, Emission-Computed / Q000379:methods; D014057:Tomography, X-Ray Computed / Q000379:methods; D051598:Whole Body Imaging / Q000379:methods
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D013669:Technetium Tc 99m Medronate